Anti-Tumor Activity of Single-Agent Sunitinib Malate in Advanced Gastric Cancer Preliminary results from a new Phase II research provide data on the anti-tumor activity and tolerability of sunitinib malate in patients with advanced gastric cancer. Additionally, data from stage I studies provide information on the tolerability and security of sunitinib malate in conjunction with current standard of care chemotherapies in the treatment of hormone-refractory prostate malignancy and advanced breast cancer. These data were shown this week at the 14th European Tumor Conference in Barcelona farmacia italiana http://tadalafil-italia.net . Gastric cancer is the 4th most common type of cancer world-wide. The development of gastric cancers has been linked to chronic an infection with H.
This new evidence should demonstrate instrumental in comprising antibiotic prescribing. .. Antibiotic prescribing should be standardized across Europe to help tackle resistance Antibiotic prescribing for respiratory illnesses ought to be standardised across Europe in reducing inappropriate prescribing and resistance, say professionals in a study published on bmj.com. Antibiotic resistance is an evergrowing problem worldwide. In European countries, 39 percent of invasive bacterias were resistant to penicillin in 2006 and needless antibiotic prescribing, for respiratory illnesses particularly, has been blamed for raising antibiotic resistance. Some evidence also suggests that most antibiotic prescriptions usually do not help these patients get better any quicker, although the results are unclear still.